X

Twitter

Twitter

Test Twitter

TAZVERIK® Mechanism of Action

Tazverik is the first and only FDA-approved EZH2 inhibitor. Watch this video to see how Tazverik inhibits both MT and WT EZH2.

06/21/2021
TAZVERIK® (tazemetostat) Interactive Experience

Explore this new interactive resource for a closer look at Taverik efficacy, safety, mechanism of action, and more.

06/21/2021
Immunotherapy Combo Checks Progression in Advanced Melanoma

Researchers have used two immunotherapy drugs to target and block different protein checkpoints, significantly increasing the time before melanoma progressed in new patients with...

Oncology Times - Latest Articles
07/05/2021

source list reference

#7d60d9
#2694a4
#32a887
#85eb24
#352625
#4d4537
#d2093c
#8e3f1c
#76b6c3
#bfcfc8
#c61417
#67e25b
#efef71
#03cffc
#42fc9a
#cc529a
#c59445
#c8cc0c
#bf6be3
#e8085a
#97d1a0
#74e391
#eb6342
#b61f77
#a153ac
#e7f6e3
#6fc969
#9a8c2c
#a9c507
#2b9ab3
#e61923
#990677
#4a7bab
#89f67c
#49a21d
#2c990a
#d7da81
#f5ce42
#575662
#a60538
#49cde9
#c20fce
#d95d39
#eb5834